• Elaine M Griffeth, Brian Whitson, David Huard, and Brent R Brown.
• College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma. Electronic address: griffeth.elaine@mayo.edu.
• Am. J. Med. Sci. 2021 Jan 1; 361 (1): 111-117.

AbstractEndobronchial lipomas are rare benign tumors that can cause bronchial obstruction resulting in significant symptoms and post-obstructive parenchymal damage. Accurate diagnosis and treatment are essential to avoid unnecessary morbidity and mortality in these patients. We describe one case of endobronchial lipoma at our institution and include a literature review of endobronchial lipoma cases reported during the time period 2003-2018. Treatment has shifted towards bronchoscopic management and away from surgery for the majority of patients; 64.3% of patients in this review had their lipoma resected bronchoscopically, compared to 30% or less in reviews as recent as 2003. Notably, in cases reported since 2010, 72.7% of cases were managed bronchoscopically. Recurrence rates are low following both bronchoscopic and surgical resection.Copyright © 2020 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.

22 keywords...

hide…